Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Safety and Efficiency of the Medical Device Called PacePress to Prevent Hemorrhagic Complications in Patients With High Bleeding Risk Undergoing CIED Implantation Procedures in an Open-label, Multi-Centre Clinical Trial.

NCT05292326 is registered in ClinicalTrials.gov with Medinice S.A. as lead sponsor.

NCT NCT05292326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05292326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Safety and Efficiency of the Medical Device Called PacePress to Prevent Hemorrhagic Complications in Patients With High Bleeding Risk Undergoing CIED Implantation Procedures in an Open-label, Multi-Centre Clinical Trial.
Lead sponsor
Medinice S.A.
Phase
Not applicable
Overall status
Terminated
Start date
May 25, 2021
Completion date
March 14, 2025
Enrollment
122 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

hematoma, hemorrhage, hemorrhagic complications, pathologic processes